Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Psychiatry Reports
Published in: Current Psychiatry Reports 11/2018

01-11-2018 | Reproductive Psychiatry and Women's Health (CN Epperson and L Hantsoo, Section Editors)

Suicide Risk and the Menstrual Cycle: a Review of Candidate RDoC Mechanisms

Authors: Sarah A. Owens, Tory Eisenlohr-Moul

Published in: Current Psychiatry Reports | Issue 11/2018

Login to get access

Abstract

Purpose of Review

Risk for suicidal behavior may fluctuate across the menstrual cycle. Here, we use the RDoC framework to review potential mechanisms by which the cycle may increase acute suicide risk.

Recent Findings

The menstrual cycle impacts the majority of RDoC constructs linked to suicide risk, particularly among hormone-sensitive women, such as those with premenstrual dysphoric disorder or premenstrual exacerbation of a psychiatric disorder. Despite this, there are no published studies examining suicidal ideation, planning, or behavior longitudinally across the cycle.

Summary

More work is needed to understand how hormone sensitivity may relate to both trait and state suicide risk. Intensive multilevel investigations of cyclical hormone effects on suicide risk through specific RDoC mechanisms are suggested. This is a fertile research area and may provide key insights regarding the mechanisms of acute suicide risk.
Footnotes
1
Although we use the term “women” throughout for readability, we wish to clarify that we use this word to indicate those assigned female at birth who are currently experiencing natural menstrual cycles. This may include transgender men and nonbinary-identified individuals.
 
Literature
1.
Heron M. Deaths: Leading Causes for 2013. Hyattsville: National Center for Health Statistics; 2016. Report No.: 2
2.
Shepard DS, Gurewich D, Lwin AK, Reed GA, Silverman MM. Suicide and suicidal attempts in the United States: costs and policy implications. Suicide Life Threat Behav. 2016;46(3):352–62.PubMed
3.
4.
• Franklin JC, Ribeiro JD, Fox KR, Bentley KH, Kleiman EM, Huang X, et al. Risk factors for suicidal thoughts and behaviors: a meta-analysis of 50 years of research. Psychol Bull. 2017;143(2):187–232. A meta-analytic review of risk factors for suicidal thoughts and behaviors. PubMed
5.
•• Glenn CR, Cha CB, Kleiman EM, Nock MK. Understanding suicide risk within the Research Domain Criteria (RDoC) framework: insights, challenges, and future cesearch Considerations. Clin Psychol Sci J Assoc Psychol Sci. 2017;5(3):568–92. A review of established suicide risk factors using the RDoC framework.
6.
• Miller AB, Eisenlohr-Moul T, Giletta M, Hastings PD, Rudolph KD, Nock MK, et al. A within-person approach to risk for suicidal ideation and suicidal behavior: examining the roles of depression, stress, and abuse exposure. J Consult Clin Psychol. 2017;85(7):712–22. A discussion and demonstration of integrating between- and within-person factors in the prediction of acute suicidal behavior. PubMedPubMedCentral
7.
•• Schiller CE, Johnson SL, Abate AC, Schmidt PJ, Rubinow DR. Reproductive steroid regulation of mood and behavior. Compr Physiol. 2016;6(3):1135–60. A comprehensive review of ovarian steroid effects on mood, cognition, and behavior emphasizing neurobiology and unique effects in reproductive mood disorders. PubMed
8.
Nock MK, Borges G, Bromet EJ, Cha CB, Kessler RC, Lee S. Suicide and suicidal behavior. Epidemiol Rev. 2008;30:133–54.PubMedPubMedCentral
9.
Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998 Jan 22;338(4):209–16.PubMed
10.
Eisenlohr-Moul TA, Girdler SS, Schmalenberger KM, Dawson DN, Surana P, Johnson JL, et al. Toward the reliable diagnosis of DSM-5 premenstrual dysphoric disorder: the Carolina Premenstrual Assessment Scoring System (C-PASS). Am J Psychiatry. 2017 Jan 1;174(1):51–9.PubMed
11.
• Hantsoo L, Epperson CN. Premenstrual dysphoric disorder: epidemiology and treatment. Curr Psychiatry Rep. 2015;17(11):87. Up-to-date overview of the etiology and treatment of premenstrual dysphoric disorder. PubMedPubMedCentral
12.
Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. 2003;28(Suppl 3):1–23.PubMed
13.
Hartlage SA, Brandenburg DL, Kravitz HM. Premenstrual exacerbation of depressive disorders in a community-based sample in the United States. Psychosom Med. 2004 Oct;66(5):698–706.PubMed
14.
Eisenlohr-Moul TA, Rubinow DR, Schiller CE, Johnson JL, Leserman J, Girdler SS. Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder. Psychoneuroendocrinology. 2016 May;67:142–52.PubMedPubMedCentral
15.
Gollenberg AL, Hediger ML, Mumford SL, Whitcomb BW, Hovey KM, Wactawski-Wende J, et al. Perceived stress and severity of perimenstrual symptoms: the BioCycle study. J Womens Health. 2010 May;19(5):959–67.
16.
Namavar Jahromi B, Pakmehr S, Hagh-Shenas H. Work stress, premenstrual syndrome and dysphoric disorder: are there any associations? Iran Red Crescent Med J. 2011 Mar;13(3):199–202.PubMedPubMedCentral
17.
•• Eisenlohr-Moul TA, DeWall CN, Girdler SS, Segerstrom SC. Ovarian hormones and borderline personality disorder features: Preliminary evidence for interactive effects of estradiol and progesterone. Biol Psychol. 2015;109:37–52. Presentation of a standardized scoring method for diagnosing degree of menstrual cyclicity in research and clinical settings. PubMedPubMedCentral
18.
Roberts B, Eisenlohr-Moul T, Martel MM. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018 Feb 1;88:105–14.PubMed
19.
Edler C, Lipson SF, Keel PK. Ovarian hormones and binge eating in bulimia nervosa. Psychol Med. 2007 Jan;37(1):131–41.PubMed
20.
•• Eisenlohr-Moul TA, Schmalenberger KM, Owens SA, Peters JR, Dawson DN, Girdler SS. Perimenstrual exacerbation of symptoms in borderline personality disorder: evidence from multilevel models and the Carolina Premenstrual Assessment Scoring System. Psychol Med. 2018;28:1–11. Prospective study demonstrating high risk of perimenstrual exacerbation in women with BPD, a clinical group at high risk of suicide.
21.
Teatero ML, Mazmanian D, Sharma V. Effects of the menstrual cycle on bipolar disorder. Bipolar Disord. 2014 Feb;16(1):22–36.PubMed
22.
Martel MM, Eisenlohr-Moul T, Roberts B. Interactive effects of ovarian steroid hormones on alcohol use and binge drinking across the menstrual cycle. J Abnorm Psychol. 2017 Nov;126(8):1104–13.PubMed
23.
•• Nillni YI, Pineles SL, Patton SC, Rouse MH, Sawyer AT, Rasmusson AM. Menstrual cycle effects on psychological symptoms in women with PTSD. J Trauma Stress. 2015;28(1):1–7. Prospective study demonstrating risk of premenstrual exacerbation in women with PTSD, a clinical group at high risk of suicide. PubMed
24.
Saunders KEA, Hawton K. Suicidal behaviour and the menstrual cycle. Psychol Med. 2006;36(7):901–12.PubMed
25.
26.
Baca-Garcia E, Diaz-Sastre C, Ceverino A, Perez-Rodriguez MM, Navarro-Jimenez R, Lopez-Castroman J, et al. Suicide attempts among women during low estradiol/low progesterone states. J Psychiatr Res. 2010;44(4):209–14.PubMed
27.
Dogra TD, Leenaars AA, Raintji R, Lalwani S, Girdhar S, Wenckstern S, et al. Menstruation and suicide: an exploratory study. Psychol Rep. 2007;101(2):430–4.PubMed
28.
29.
Eisenlohr-Moul T, Prinstein M, Rubinow D, Young S, Walsh E, Bowers S, et al. S104. Ovarian steroid withdrawal underlies perimenstrual worsening of suicidality: evidence from a crossover steroid stabilization trial. Biol Psychiatry. 2018;83(9, Supplement):S387.
30.
Giletta M, Calhoun CD, Hastings PD, Rudolph KD, Nock MK, Prinstein MJ. Multi-level risk factors for suicidal ideation among at-risk adolescent females: the role of hypothalamic-pituitary-adrenal axis responses to stress. J Abnorm Child Psychol. 2015;43(5):807–20.PubMedPubMedCentral
31.
Dombrovski AY, Hallquist MN. The decision neuroscience perspective on suicidal behavior: evidence and hypotheses. Curr Opin Psychiatry. 2017;30(1):7–14.PubMedPubMedCentral
32.
Ducasse D, Loas G, Dassa D, Gramaglia C, Zeppegno P, Guillaume S, et al. Anhedonia is associated with suicidal ideation independently of depression: a meta-analysis. Depress Anxiety. 2018;35(5):382–92.PubMed
33.
Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999;56(7):617–26.PubMed
34.
Franklin JC, Hessel ET, Prinstein MJ. Clarifying the role of pain tolerance in suicidal capability. Psychiatry Res. 2011;189(3):362–7.PubMed
35.
Van Orden KA, Witte TK, Cukrowicz KC, Braithwaite S, Selby EA, Joiner TE. The interpersonal theory of suicide. Psychol Rev. 2010;117(2):575–600.PubMedPubMedCentral
36.
Mościcki EK. Epidemiology of completed and attempted suicide: toward a framework for prevention. Clin Neurosci Res. 2001;1(5):310–23.
37.
Bolton JM, Pagura J, Enns MW, Grant B, Sareen J. A population-based longitudinal study of risk factors for suicide attempts in major depressive disorder. J Psychiatr Res. 2010;44(13):817–26.PubMedPubMedCentral
38.
Wichstrøm L. Predictors of adolescent suicide attempts: a nationally representative longitudinal study of Norwegian adolescents. J Am Acad Child Adolesc Psychiatry. 2000;39(5):603–10.PubMed
39.
Jollant F, Lawrence NS, Giampietro V, Brammer MJ, Fullana MA, Drapier D, et al. Orbitofrontal cortex response to angry faces in men with histories of suicide attempts. Am J Psychiatry. 2008;165(6):740–8.PubMed
40.
Pan LA, Hassel S, Segreti AM, Nau SA, Brent DA, Phillips ML. Differential patterns of activity and functional connectivity in emotion processing neural circuitry to angry and happy faces in adolescents with and without suicide attempt. Psychol Med. 2013;43(10):2129–42.PubMed
41.
Maniglio R, Gusciglio F, Lofrese V, Belvederi Murri M, Tamburello A, Innamorati M. Biased processing of neutral facial expressions is associated with depressive symptoms and suicide ideation in individuals at risk for major depression due to affective temperaments. Compr Psychiatry. 2014;55(3):518–25.PubMed
42.
Bernert RA, Turvey CL, Conwell Y, Joiner TE. Association of poor subjective sleep quality with risk for death by suicide during a 10-year period: a longitudinal, population-based study of late life. JAMA Psychiatry. 2014;71(10):1129–37.PubMedPubMedCentral
43.
Pigeon WR, Pinquart M, Conner K. Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry. 2012;73(9):e1160–7.PubMed
44.
Chawla A, Swindle R, Long S, Kennedy S, Sternfeld B. Premenstrual dysphoric disorder: is there an economic burden of illness? Med Care. 2002;40(11):1101–12.PubMed
45.
Dean BB, Borenstein JE, Knight K, Yonkers K. Evaluating the criteria used for identification of PMS. J Womens Health. 2006;15(5):546–55.
46.
Fontana AM, Badawy S. Perceptual and coping processes across the menstrual cycle: an investigation in a premenstrual syndrome clinic and a community sample. Behav Med. 1997;22(4):152–9.PubMed
47.
Fontana AM, Palfai TG. Psychosocial factors in premenstrual dysphoria: stressors, appraisal, and coping processes. J Psychosom Res. 1994;38(6):557–67.PubMed
48.
Gonda X, Telek T, Juhász G, Lazary J, Vargha A, Bagdy G. Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(8):1782–8.PubMed
49.
Romans S, Clarkson R, Einstein G, Petrovic M, Stewart D. Mood and the menstrual cycle: a review of prospective data studies. Gend Med. 2012;9(5):361–84.PubMed
50.
Schwartz DH, Romans SE, Meiyappan S, De Souza MJ, Einstein G. The role of ovarian steroid hormones in mood. Horm Behav. 2012;62(4):448–54.PubMed
51.
Gingnell M, Morell A, Bannbers E, Wikström J, Sundström Poromaa I. Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder. Horm Behav. 2012;62(4):400–6.PubMed
52.
Goldstein JM, Jerram M, Poldrack R, Ahern T, Kennedy DN, Seidman LJ, et al. Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci Off J Soc Neurosci. 2005;25(40):9309–16.
53.
Ossewaarde L, Hermans EJ, van Wingen GA, Kooijman SC, Johansson I-M, Bäckström T, et al. Neural mechanisms underlying changes in stress-sensitivity across the menstrual cycle. Psychoneuroendocrinology. 2010;35(1):47–55.PubMed
54.
Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56.PubMedPubMedCentral
55.
Brundin L, Bryleva EY, Thirtamara RK. Role of inflammation in suicide: from mechanisms to treatment. Neuropsychopharmacology. 2017;42(1):271–83.PubMed
56.
Isung J, Aeinehband S, Mobarrez F, Nordström P, Runeson B, Åsberg M, et al. High interleukin-6 and impulsivity: determining the role of endophenotypes in attempted suicide. Transl Psychiatry. 2014;4(10):e470.PubMedPubMedCentral
57.
Puder JJ, Blum CA, Mueller B, Geyter CD, Dye L, Keller U. Menstrual cycle symptoms are associated with changes in low-grade inflammation. Eur J Clin Invest. 2006;36(1):58–64.PubMed
58.
Bloch M, Schmidt PJ, Rubinow DR. Premenstrual syndrome: evidence for symptom stability across cycles. Am J Psychiatry. 1997;154(12):1741–6.PubMed
59.
Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, et al. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry. 2012;169(5):465–75.PubMedPubMedCentral
60.
Freeman EW, Halberstadt SM, Rickels K, Legler JM, Lin H, Sammel MD. Core symptoms that discriminate premenstrual syndrome. J Womens Health. 2010;20(1):29–35.
61.
Hartlage SA, Arduino KE. Toward the content validity of premenstrual dysphoric disorder: do anger and irritability more than depressed mood represent treatment-seekers’ experiences? Psychol Rep. 2002;90(1):189–202.PubMed
62.
Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J Affect Disord. 2005;85(3):275–82.PubMed
63.
Stein MB, Schmidt PJ, Rubinow DR, Uhde TW. Panic disorder and the menstrual cycle: panic disorder patients, healthy control subjects, and patients with premenstrual syndrome. Am J Psychiatry. 1989;146(10):1299–303.PubMed
64.
Epperson CN, Pittman B, Czarkowski KA, Stiklus S, Krystal JH, Grillon C. Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology. 2007;32(10):2190–8.PubMedPubMedCentral
65.
Welz A, Huffziger S, Reinhard I, Alpers GW, Ebner-Priemer U, Kuehner C. Anxiety and rumination moderate menstrual cycle effects on mood in daily life. Women Health. 2016;56(5):540–60.PubMed
66.
Kaspi SP, Otto MW, Pollack MH, Eppinger S, Rosenbaum JF. Premenstrual exacerbation of symptoms in women with panic disorder. J Anxiety Disord. 1994;8(2):131–8.
67.
Nillni YI, Rohan KJ, Zvolensky MJ. The role of menstrual cycle phase and anxiety sensitivity in catastrophic misinterpretation of physical symptoms during a CO(2) challenge. Arch Womens Ment Health. 2012;15(6):413–22.PubMedPubMedCentral
68.
Law KC, Khazem LR, Anestis MD. The role of emotion dysregulation in suicide as considered through the ideation to action framework. Curr Opin Psychol. 2015;3:30–5.
69.
Melhem NM, Keilp JG, Porta G, Oquendo MA, Burke A, Stanley B, et al. Blunted HPA Axis activity in suicide attempters compared to those at high risk for suicidal behavior. Neuropsychopharmacology. 2016;41(6):1447–56.PubMed
70.
Craner JR, Sigmon ST, Young MA. Self-focused attention and symptoms across menstrual cycle phases in women with and without premenstrual disorders. Cogn Ther Res. 2016;40(1):118–27.
71.
Wu M, Zhou R, Huang Y. Effects of menstrual cycle and neuroticism on females’ emotion regulation. Int J Psychophysiol. 2014;94(3):351–7.PubMed
72.
Manikandan S, Nillni YI, Zvolensky MJ, Rohan KJ, Carkeek KR, Leyro TM. The role of emotion regulation in the experience of menstrual symptoms and perceived control over anxiety-related events across the menstrual cycle. Arch Womens Ment Health. 2016;19(6):1109–17.PubMed
73.
Girdler SS, Pedersen CA, Straneva PA, Leserman J, Stanwyck CL, Benjamin S, et al. Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder. Psychiatry Res. 1998;81(2):163–78.PubMed
74.
Girdler SS, Sherwood A, Hinderliter AL, Leserman J, Costello NL, Straneva PA, et al. Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. Psychosom Med. 2003;65(5):849–56.PubMed
75.
Lee EE, Nieman LK, Martinez PE, Harsh VL, Rubinow DR, Schmidt PJ. ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement. J Clin Endocrinol Metab. 2012;97(6):1887–96.PubMedPubMedCentral
76.
Dreher J-C, Schmidt PJ, Kohn P, Furman D, Rubinow D, Berman KF. Menstrual cycle phase modulates reward-related neural function in women. Proc Natl Acad Sci U S A. 2007;104(7):2465–70.PubMedPubMedCentral
77.
Bayer J, Bandurski P, Sommer T. Differential modulation of activity related to the anticipation of monetary gains and losses across the menstrual cycle. Eur J Neurosci. 2013;38(10):3519–26.PubMed
78.
Ossewaarde L, van Wingen GA, Kooijman SC, Bäckström T, Fernández G, Hermans EJ. Changes in functioning of mesolimbic incentive processing circuits during the premenstrual phase. Soc Cogn Affect Neurosci. 2011;6(5):612–20.PubMed
79.
Jones BC, Hahn AC, Fisher CI, Wang H, Kandrik M, DeBruine LM. General sexual desire, but not desire for uncommitted sexual relationships, tracks changes in women’s hormonal status. Psychoneuroendocrinology. 2018;88:153–7.PubMed
80.
Roney JR, Simmons ZL. Hormonal predictors of sexual motivation in natural menstrual cycles. Horm Behav. 2013;63(4):636–45.PubMed
81.
Roney JR, Simmons ZL. Within-cycle fluctuations in progesterone negatively predict changes in both in-pair and extra-pair desire among partnered women. Horm Behav. 2016;81:45–52.PubMed
82.
Diekhof EK. Be quick about it. Endogenous estradiol level, menstrual cycle phase and trait impulsiveness predict impulsive choice in the context of reward acquisition. Horm Behav. 2015;74:186–93.PubMed
83.
Smith CT, Sierra Y, Oppler SH, Boettiger CA. Ovarian cycle effects on immediate reward selection bias in humans: a role for estradiol. J Neurosci Off J Soc Neurosci. 2014;34(16):5468–76.
84.
• Leeners B, Kruger THC, Geraedts K, Tronci E, Mancini T, Ille F, et al. Lack of associations between female hormone levels and visuospatial working memory, divided attention and cognitive bias across two consecutive menstrual cycles. Front Behav Neurosci. 2017 [cited 2018 Jun 9];11. Available from: https://​www.​frontiersin.​org/​articles/​10.​3389/​fnbeh.​2017.​00120/​full. Prospective study demonstrating no robust effects of the cycle on cognitive function in healthy women.
85.
Owens JF, Matthews KA, Everson SA. Cognitive function effects of suppressing ovarian hormones in young women. Menopause. 2002;9(4):227–35.PubMed
86.
Schmidt PJ, Keenan PA, Schenkel LA, Berlin K, Gibson C, Rubinow DR. Cognitive performance in healthy women during induced hypogonadism and ovarian steroid addback. Arch Womens Ment Health. 2013;16(1):47–58.PubMed
87.
Jacobs E, D’Esposito M. Estrogen shapes dopamine-dependent cognitive processes: implications for women’s health. J Neurosci Off J Soc Neurosci. 2011;31(14):5286–93.
88.
Wishart HA, Roth RM, Saykin AJ, Rhodes CH, Tsongalis GJ, Pattin KA, et al. COMT Val158Met genotype and individual differences in executive function in healthy adults. J Int Neuropsychol Soc. 2011;17(1):174–80.PubMed
89.
Amin Z, Epperson CN, Constable RT, Canli T. Effects of estrogen variation on neural correlates of emotional response inhibition. NeuroImage. 2006;32(1):457–64.PubMed
90.
Colzato LS, Pratt J, Hommel B. Estrogen modulates inhibition of return in healthy human females. Neuropsychologia. 2012;50(1):98–103.PubMed
91.
Protopopescu X, Pan H, Altemus M, Tuescher O, Polanecsky M, McEwen B, et al. Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc Natl Acad Sci U S A. 2005;102(44):16060–5.PubMedPubMedCentral
92.
Colzato LS, Hertsig G, van den Wildenberg WPM, Hommel B. Estrogen modulates inhibitory control in healthy human females: evidence from the stop-signal paradigm. Neuroscience. 2010;167(3):709–15.PubMed
93.
Huo L, Straub RE, Roca C, Schmidt PJ, Shi K, Vakkalanka R, et al. Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry. 2007;62(8):925–33.PubMedPubMedCentral
94.
Carpenter MJ, Upadhyaya HP, LaRowe SD, Saladin ME, Brady KT. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine Tob Res. 2006;8(5):627–38.PubMed
95.
Epstein EE, Rhines KC, Cook S, Zdep-Mattocks B, Jensen NK, Mccrady BS. Changes in alcohol craving and consumption by phase of menstrual cycle in alcohol dependent women. J Subst Use. 2006;11(5):323–32.
96.
Evans SM, Levin FR. Response to alcohol in women: role of the menstrual cycle and a family history of alcoholism. Drug Alcohol Depend. 2011;114(1):18–30.PubMedPubMedCentral
97.
Schiller CE, Saladin ME, Gray KM, Hartwell KJ, Carpenter MJ. Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol. 2012;20(4):251–7.PubMedPubMedCentral
98.
Klump KL, Keel PK, Culbert KM, Edler C. Ovarian hormones and binge eating: exploring associations in community samples. Psychol Med. 2008;38(12):1749–57.PubMedPubMedCentral
99.
Protopopescu X, Tuescher O, Pan H, Epstein J, Root J, Chang L, et al. Toward a functional neuroanatomy of premenstrual dysphoric disorder. J Affect Disord. 2008;108(1):87–94.PubMed
100.
Iacovides S, Avidon I, Baker FC. Does pain vary across the menstrual cycle? A review. Eur J Pain Lond Engl. 2015;19(10):1389–405.
101.
de Tommaso M. Pain perception during menstrual cycle. Curr Pain Headache Rep. 2011;15(5):400–6.PubMed
102.
Straneva PA, Maixner W, Light KC, Pedersen CA, Costello NL, Girdler SS. Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder. Health Psychol. 2002;21(4):358–67.PubMed
103.
Smith A, Miller S, Bodell L, Ribeiro J, Joiner T, Maner J. Cycles of risk: associations between menstrual cycle and suicidal ideation among women. Personal Individ Differ. 2015;74:35–40.
104.
Schultheiss OC, Dargel A, Rohde W. Implicit motives and gonadal steroid hormones: effects of menstrual cycle phase, oral contraceptive use, and relationship status. Horm Behav. 2003;43(2):293–301.PubMed
105.
106.
Rubinow DR, Smith MJ, Schenkel LA, Schmidt PJ, Dancer K. Facial emotion discrimination across the menstrual cycle in women with premenstrual dysphoric disorder (PMDD) and controls. J Affect Disord. 2007;104(1–3):37–44.PubMedPubMedCentral
107.
Baker FC, Driver HS. Circadian rhythms, sleep, and the menstrual cycle. Sleep Med. 2007;8(6):613–22.PubMed
108.
Lamarche LJ, Driver HS, Wiebe S, Crawford L, DE Koninck JM. Nocturnal sleep, daytime sleepiness, and napping among women with significant emotional/behavioral premenstrual symptoms. J Sleep Res. 2007;16(3):262–8.PubMed
109.
Shechter A, Lespérance P, Ng Y, Kin NMK, Boivin DB. Nocturnal polysomnographic sleep across the menstrual cycle in premenstrual dysphoric disorder. Sleep Med. 2012;13(8):1071–8.PubMed
110.
Shechter A, Varin F, Boivin DB. Circadian variation of sleep during the follicular and luteal phases of the menstrual cycle. Sleep. 2010;33(5):647–56.PubMedPubMedCentral
111.
• Zheng H, Harlow SD, Kravitz HM, Bromberger J, Buysse DJ, Matthews KA, et al. Actigraphy-defined measures of sleep and movement across the menstrual cycle in midlife menstruating women: Study of Women’s Health Across the Nation Sleep Study. Menopause. 2015;22(1):66–74. Large prospective study demonstrating effects of the menstrual cycle on sleep. PubMedPubMedCentral
112.
Baker FC, Sassoon SA, Kahan T, Palaniappan L, Nicholas CL, Trinder J, et al. Perceived poor sleep quality in the absence of polysomnographic sleep disturbance in women with severe premenstrual syndrome. J Sleep Res. 2012;21(5):535–45.PubMedPubMedCentral
113.
Baker FC, Colrain IM, Trinder J. Reduced parasympathetic activity during sleep in the symptomatic phase of severe premenstrual syndrome. J Psychosom Res. 2008;65(1):13–22.PubMedPubMedCentral
114.
Baker FC, Kahan TL, Trinder J, Colrain IM. Sleep quality and the sleep electroencephalogram in women with severe premenstrual syndrome. Sleep. 2007;30(10):1283–91.PubMedPubMedCentral
115.
Baker FC, Colrain IM. Daytime sleepiness, psychomotor performance, waking EEG spectra and evoked potentials in women with severe premenstrual syndrome. J Sleep Res. 2010;19(1 Pt 2):214–27.PubMed
116.
Sundström I, Bäckström T. Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects. Biol Psychiatry. 1998;44(8):755–64.PubMed
117.
McCall WV, Black CG. The link between suicide and insomnia: theoretical mechanisms. Curr Psychiatry Rep. 2013;15(9):389.PubMedPubMedCentral
118.
119.
Metadata
Title
Suicide Risk and the Menstrual Cycle: a Review of Candidate RDoC Mechanisms
Authors
Sarah A. Owens
Tory Eisenlohr-Moul
Publication date
01-11-2018
Publisher
Springer US
Published in
Current Psychiatry Reports / Issue 11/2018
Print ISSN: 1523-3812
Electronic ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-018-0962-3

Other articles of this Issue 11/2018

Current Psychiatry Reports 11/2018 Go to the issue

Disaster Psychiatry: Trauma, PTSD, and Related Disorders (M J Friedman, Section Editor)

Posttraumatic Stress Disorder and Death From Suicide

Reproductive Psychiatry and Women's Health (CN Epperson and L Hantsoo, Section Editors)

Examining the Relationship Between Neurosteroids, Cognition, and Menopause With Neuroimaging Methods

Sex and Gender Issues in Behavioral Health (CN Epperson and L Hantsoo, Section Editors)

Sex Differences in Vulnerability to Prenatal Stress: a Review of the Recent Literature

Child and Adolescent Disorders (T Benton, Section Editor)

Attention-Deficit/Hyperactivity Disorder and Transitional Aged Youth

Public Policy and Public Health (G Norquist, Section Editor)

Social Determinants of Mental Health: Where We Are and Where We Need to Go

Child and Adolescent Disorders (T Benton, Section Editor)

Autism Spectrum Disorder and Transition-Aged Youth